Related Experiment Videos
Breast carcinoma: MR imaging before re-excisional biopsy
S G Orel1, C Reynolds, M D Schnall
1Department of Radiology, University of Pennsylvania Medical Center, Philadelphia 19104, USA.
Radiology
|November 14, 1997
Summary
Magnetic resonance (MR) imaging helps detect residual breast cancer after excisional biopsy. While MR imaging shows high accuracy in identifying remaining tumors, postsurgical changes can limit its effectiveness.
Area of Science:
- Radiology
- Oncology
- Breast Imaging
Background:
- Excisional biopsy is a common procedure for breast carcinoma.
- Accurate assessment of residual disease post-biopsy is crucial for treatment planning.
- Limitations exist in conventional imaging modalities for detecting residual tumor extent.
Purpose of the Study:
- To evaluate the diagnostic performance of magnetic resonance (MR) imaging.
- To assess MR imaging's role in identifying residual breast carcinoma after excisional biopsy.
- To determine if MR imaging can guide decisions before re-excision surgery.
Main Methods:
- Contrast-enhanced MR imaging was performed on 47 patients.
- Patients underwent MR imaging after initial excisional biopsy and before further surgery.
- Data analyzed for positive and negative predictive values of MR imaging.
Main Results:
- MR imaging demonstrated an 82% positive predictive value for residual disease.
- Sixteen percent of patients (14/47) had multifocal or diffuse residual carcinoma.
- In 4 patients, MR imaging findings led to a change in management, including mastectomy.
Conclusions:
- MR imaging is valuable for detecting residual breast cancer after excisional biopsy.
- It can identify unsuspected multifocal or extensive disease, supporting mastectomy over re-excision.
- Postsurgical changes and enhancement of benign tissue are limitations to consider.